UTv Videos

The study compared patient experiences with silicone vs polyurethane ureteral stents.

“It is possible to conserve fluid when we're trying to do these procedures without compromising patient care," says Roshan M. Patel, MD.

The test demonstrated comparable or superior performance in Black and Non-White men.

"We...observed an exceedingly high degree of safety across the board, with very few complications,” says Jared S. Winoker, MD.

Jim C. Hu, MD, MPH, shares in-depth findings comparing urinary continence recovery across 3 RARP approaches.

“We're now entering an era of new types of technologies to treat BPH in a minimally invasive fashion,” says Dean Elterman, MD.

“What [we] found was that those men who received a penile implant had a significant reduction in depression and psychological distress," says Mohit Khera, MD, MBA, MPH.

In this video, part 4 of a 4-part series, panelists discuss how primary care providers can address patient questions on prostate cancer screening.

In this video, part 3 of a 4-part series, panelists discuss treatment planning for prostate cancer, particularly in older patients.

In this video, part 2 of a 4-part series, panelists discuss the increasing prevalence of de novo metastatic hormone-sensitive prostate cancer.

In this video, part 1 of a 4-part series, panelists discuss the nuances and challenges of prostate cancer screening.

Jared S. Winoker, MD, addresses the wide range of stone burdens treated by the CVAC system for the study.

A prostate cancer expert breaks down likelihood of a diagnosis of metastatic prostate cancer and touches on available treatment options.

The AI tool outperformed MRI in assessing for SVI.

Karyn S. Eilber, MD, discusses treatment of genitourinary syndrome of menopause.

The risk of stricture formation was 4.6% in the TFL cohort vs 2.4% in the holmium laser cohort.

According to Adam B. Weiner, MD, a urologist at Cedars-Sinai Medical Center, men should begin prostate cancer screening around ages 50 to 55.

"There was a significant increase in overall fatigue after performing flexible ureteroscopy," says Sarah Razavi, MD.

“I think it does give us confidence that clinical trials can predict how these drugs will work in the real world," says Stephen J. Freedland, MD.

“The key finding is [that] this might be, in itself, a novel risk factor for bladder cancer," says Laura E. Davis, MD.

Nearly 60% of patients taking vibegron remained on treatment at 1 year.

An expert details key post-procedural recommendations following onabotulinumtoxinA injection for OAB.

Recent data suggest that obesity may be a risk factor for increased pain on transperineal biopsy.

An expert walks through specific actions that urologists and their teams can take before, during, and after the procedure.

Among the guideline’s recommendations is the use of local low-dose vaginal estrogen as first-line therapy for GSM.

The study was published in JCO Oncology Practice.

Joshua M. Heiman, MD, details key findings from the POuND OUT study.